Skip to main content
Premium Trial:

Request an Annual Quote

Finnish Red Cross Licenses Ariadne Genomics' Software

NEW YORK (GenomeWeb News) – The Finnish Red Cross has licensed Ariadne Genomics’ Pathway Studio Enterprise software for use in modeling diseases and studying biological pathways, the company said today.
 
The Finnish scientists plan to use the software to extract information from text; to create databases about diseases, organisms, and cell types; and to study diseases and identify risk groups.
 
The software allows the scientists to “add and update databases, expand the database content, and work with our own and third-party data,” said Finnish Red Cross bioinfromatician Pauli Ojala.
 
Ariadne European Sales Manager Olivier Brun said that the Finnish scientists “have created several different pipelines that process literature and automatically update their custom human and non-mammalian databases."
 
The software includes the ResNet database, which includes more than one million unique molecular interactions and relationships from literature, in addition to tools to query the database, create molecular networks, and interpret gene expression data, the Rockville, Md.-based company said.
 
Financial terms of the agreement were not released.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.